AI Verdict
ZTS has stronger fundamentals based on our AI analysis.
MRK vs ZTS Fundamental Comparison
| Metric | MRK | ZTS |
|---|---|---|
| Revenue | $16.3B | $2.3B |
| Net Income | $-4.2B | $601.0M |
| Net Margin | -26.0% | 26.6% |
| ROE | -9.2% | 18.6% |
| ROA | -3.3% | 4.0% |
| Current Ratio | 1.30x | 3.15x |
| Debt/Equity | 1.02x | 2.80x |
| EPS | $-1.72 | $1.42 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MRK vs ZTS: Frequently Asked Questions
Is MRK or ZTS the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ZTS has stronger fundamentals. MRK is graded B (78% confidence) while ZTS is graded A (78% confidence). This is not investment advice.
How does MRK compare to ZTS fundamentally?
Merck & Co., Inc. has ROE of -9.2% vs Zoetis Inc.'s 18.6%. Net margins are -26.0% vs 26.6% respectively.
Which stock pays higher dividends, MRK or ZTS?
MRK has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MRK or ZTS for long term?
For long-term investing, consider that MRK has a B grade with 78% confidence, while ZTS has a A grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MRK vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MRK vs ZTS, the AI consensus favors ZTS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.